Features of drugs used in inflammatory bowel disease

被引：0
|
作者：
Gangl, A. [1 ]
机构：
[1] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria
来源：
IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE | 2008年 / 159卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：176 / 186
页数：11
相关论文
共 50 条
  • [1] Features of drugs used in inflammatory bowel disease: 5-aminosalicylic acid (mesalazine)
    Klotz, U.
    IBD 2007 - ACHIEVEMENTS IN RESEARCH AND CLINICAL PRACTICE, 2008, 159 : 145 - 152
  • [2] INHIBITION OF LEUKOCYTE MOTILITY BY DRUGS USED IN INFLAMMATORY BOWEL-DISEASE
    RHODES, JM
    JEWELL, DP
    GUT, 1980, 21 (05) : A452 - A453
  • [3] Drugs for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1680): : 105 - +
  • [4] Drugs for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1448): : 59 - 66
  • [5] Drugs for Inflammatory Bowel Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2018, 60 (1550): : 107 - 114
  • [6] Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
    Quetglas, E. G.
    Armuzzi, A.
    Wigge, S.
    Fiorino, G.
    Barnscheid, L.
    Froelich, M.
    Danese, Silvio
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 71 (07) : 773 - 799
  • [7] Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment
    E. G. Quetglas
    A. Armuzzi
    S. Wigge
    G. Fiorino
    L. Barnscheid
    M. Froelich
    Silvio Danese
    European Journal of Clinical Pharmacology, 2015, 71 : 773 - 799
  • [8] RISK-BENEFIT ASSESSMENT OF DRUGS USED IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    HANAUER, SB
    STATHOPOULOS, G
    DRUG SAFETY, 1991, 6 (03) : 192 - 219
  • [9] Profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel disease
    Suarez Ferrer, C. J.
    Mesonero, F.
    Caballol, B.
    Ballester, M. P.
    Baston Rey, I.
    Castano Garcia, A.
    MIranda Bautista, J.
    Saiz Chumillas, R.
    Benitez, J. M.
    Sanchez Delgado, L.
    Lopez-Garcia, A.
    Rubin de Celio, C.
    Alonso Abreu, I.
    Melcarne, L.
    Plaza Santos, R.
    Marques Cami, M.
    Caballero Mateos, A.
    Gomez Diez, C.
    Calafat, M.
    Alonso Galan, H.
    Vega Vilaamil, P.
    Castro Sensosian, B.
    Guerro Moya, A.
    Rodriguez Diaz, C. Y.
    Spicakova, K.
    Mancenido Marcos, N.
    Molina, G.
    De Castro, L.
    Rodriguez Angulo, A.
    Cuevas del Campo, L.
    Rodriguez Grau, M. C.
    Ramirez, F.
    Gomez Pastrana, B.
    Gonzalez Partida, I.
    Botella Mateu, B.
    Pena Gonzalez, E.
    Iyo, E.
    Elosua Gonzalez, A.
    Manosa Ciria, M.
    Barreiro-De Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I449 - I450
  • [10] Profile of elderly patients in which biological drugs are used for the treatment of inflammatory bowel disease
    Suarez Ferrer, C. J.
    Mesonero, F.
    Caballol, B.
    Ballester, M. P.
    Baston Rey, I.
    Castano Garcia, A.
    MIranda Bautista, J.
    Saiz Chumillas, R.
    Benitez, J. M.
    Sanchez Delgado, L.
    Lopez-Garcia, A.
    Rubin De Celio, C.
    Alonso Abreu, I.
    Melcarne, L.
    Plaza Santos, R.
    Marques Cami, M.
    Caballero Mateos, A.
    Gomez Diez, C.
    Calafat, M.
    Alonso Galan, H.
    Vega Vilaamil, P.
    Castro Sensosian, B.
    Guerro Moya, A.
    Rodriguez Diaz, C. Y.
    Spicakova, K.
    Mancenido Marcos, N.
    Molina, G.
    De Castro, L.
    Rodriguez Angulo, A.
    Cuevas del Campo, L.
    Rodriguez Grau, M. C.
    Ramirez, F.
    Gomez Pastrana, B.
    Gonzalez Partida, I.
    Botella Mateu, B.
    Pena Gonzalez, E.
    Iyo, E.
    Elosua Gonzalez, A.
    Manosa Ciria, M.
    Barreiro-De Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I449 - I450
12345